PL370370A1 - Zastosowanie ekstraktów z roślin rodzaju Cimicifuga jako organoselektywnych środków leczniczych do leczenia chorób układu moczowo-płciowego zależnychod hormonów płciowych - Google Patents

Zastosowanie ekstraktów z roślin rodzaju Cimicifuga jako organoselektywnych środków leczniczych do leczenia chorób układu moczowo-płciowego zależnychod hormonów płciowych

Info

Publication number
PL370370A1
PL370370A1 PL02370370A PL37037002A PL370370A1 PL 370370 A1 PL370370 A1 PL 370370A1 PL 02370370 A PL02370370 A PL 02370370A PL 37037002 A PL37037002 A PL 37037002A PL 370370 A1 PL370370 A1 PL 370370A1
Authority
PL
Poland
Prior art keywords
extracts
organoselective
medicines
treating diseases
system caused
Prior art date
Application number
PL02370370A
Other languages
English (en)
Other versions
PL206937B1 (pl
Inventor
Wolfgang Wuttke
Hubertus Jarry
Volker Christoffel
Barbara Spengler
Original Assignee
Bionorica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionorica Ag filed Critical Bionorica Ag
Publication of PL370370A1 publication Critical patent/PL370370A1/pl
Publication of PL206937B1 publication Critical patent/PL206937B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
PL370370A 2001-09-19 2002-09-16 Zastosowanie ekstraktów z roślin rodzaju Cimicifuga do wytwarzania organoselektywnych środków leczniczych typu estrogenu do leczenia chorób układu moczowo-płciowego zależnych od hormonów płciowych PL206937B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10146159A DE10146159A1 (de) 2001-09-19 2001-09-19 Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes

Publications (2)

Publication Number Publication Date
PL370370A1 true PL370370A1 (pl) 2005-05-16
PL206937B1 PL206937B1 (pl) 2010-10-29

Family

ID=7699541

Family Applications (1)

Application Number Title Priority Date Filing Date
PL370370A PL206937B1 (pl) 2001-09-19 2002-09-16 Zastosowanie ekstraktów z roślin rodzaju Cimicifuga do wytwarzania organoselektywnych środków leczniczych typu estrogenu do leczenia chorób układu moczowo-płciowego zależnych od hormonów płciowych

Country Status (16)

Country Link
US (3) US7413754B2 (pl)
EP (1) EP1427430B1 (pl)
JP (1) JP2005503404A (pl)
KR (1) KR20040041619A (pl)
AT (1) ATE293985T1 (pl)
AU (1) AU2002362365A1 (pl)
BR (1) BR0212598A (pl)
DE (2) DE10146159A1 (pl)
DK (1) DK1427430T3 (pl)
EA (1) EA006164B1 (pl)
ES (1) ES2238631T3 (pl)
MX (1) MXPA04002592A (pl)
PL (1) PL206937B1 (pl)
PT (1) PT1427430E (pl)
UA (1) UA78228C2 (pl)
WO (1) WO2003024465A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745796A1 (de) 2005-07-19 2007-01-24 Bionorica Research GmbH Kombinationspräparat insbesondere zur Therapie des Prostatakarzinoms
DE102007044916A1 (de) 2007-09-19 2009-04-23 Bionorica Ag Kosmetische oder dermatologische Zusammensetzung zur topischen Verwendung
MD4025C2 (ro) * 2009-08-25 2010-10-31 Владимир КАРАУШ Remediu pentru tratamentul prostatitei şi hiperplaziei prostatei
KR101303693B1 (ko) 2011-06-30 2013-09-04 한국식품연구원 지방 대사 질환, 폐경기 질환 또는 심혈관질환 개선용 조성물
JP2013010796A (ja) * 2012-10-15 2013-01-17 Kao Corp Ｓ１００ａ８発現調節剤
IT201900000343A1 (it) * 2019-01-10 2020-07-10 Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6330417A (ja) 1986-07-23 1988-02-09 Tsumura Juntendo Inc 抗アレルギ−剤
HU204197B (en) 1986-10-30 1991-12-30 Dr Papay Valeria Tothne Process for producing extract for treating aphta, herpes, wounds in the mouth, acne, comedo and pustule
DE69002657T2 (de) 1989-02-06 1994-03-24 Den Ichi Mizuno Limulustest-positives Pflanzenglykolipid und Verfahren zur Stimulierung des Immunsystems eines Tieres.
US5716646A (en) 1990-05-01 1998-02-10 Smith; Steven A. Methods and compositions for treating arthritis
US5411733A (en) 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
CN1090498A (zh) 1993-02-01 1994-08-10 杨芳林 女用口服避孕中成药及制备方法
JP3501832B2 (ja) 1993-11-15 2004-03-02 一丸ファルコス株式会社 ヒオウギ抽出物を含有するテストステロン５α−リダクターゼ阻害剤とその応用
JP3294694B2 (ja) 1993-11-15 2002-06-24 一丸ファルコス株式会社 ヒオウギ抽出物を含有する細胞賦活剤とその応用
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH0930977A (ja) 1995-07-20 1997-02-04 Tsuneo Nanba 升麻抽出物を含有する骨疾患治療剤
EP0761204B1 (fr) 1995-09-07 1998-04-15 L'oreal Utilisation d'un extrait d'une bactérie filamenteuse non photosynthétique et composition le contenant
DE69601765T2 (de) 1995-09-07 1999-07-08 Oreal Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten
US6008208A (en) 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
SE9503775L (sv) 1995-10-26 1997-04-27 Caravan Mill Ab Tekniskt förfarande för torkning, krossning och malning av mussel- och snäckskal
US5916565A (en) * 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
CN1159340A (zh) 1996-03-11 1997-09-17 李城林 一种抗癌抑瘤药物的配方及其制作工艺
JPH107580A (ja) 1996-06-15 1998-01-13 Michio Yoshida コラゲナ−ゼ阻害剤
JP3665848B2 (ja) 1996-09-18 2005-06-29 木村 幸代 ヒメヒオウギズイセン球根抽出液の発酵飲料及びその製造方法
CN1057690C (zh) 1996-10-18 2000-10-25 宁振峰 治疗卵巢癌的中成药
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa
US5952374A (en) 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
US6039290A (en) 1998-03-16 2000-03-21 Honeywell Inc. Robust singularity avoidance in satellite attitude control
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
US20050037100A1 (en) * 1998-03-19 2005-02-17 Bionorica Ag Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
US6242012B1 (en) 1999-10-19 2001-06-05 Thomas Newmark Herbal composition for promoting hormonal balance in women and methods of using same
US20010025059A1 (en) * 2000-01-10 2001-09-27 Kastke Floyd A. Composition and method for treating non-bacterial prostatitis
US20020010141A1 (en) 2000-03-31 2002-01-24 Jonathan Ingram Isoflavones for treatment of obesity
JP2002043945A (ja) 2000-07-19 2002-02-08 Sony Corp ディジタル信号符号化装置及び方法、ディジタル信号復号装置及び方法、並びにディジタル信号伝送システム
US6326366B1 (en) 2000-08-22 2001-12-04 Protein Technologies International Hormone replacement therapy
DE10054641A1 (de) * 2000-11-03 2002-05-16 Schaper & Bruemmer Gmbh Verwendung einer Zubereitung von Cimicifuga racemosa
US20020172732A1 (en) 2001-03-21 2002-11-21 Wies Ter Laak Composition comprising cocoa

Also Published As

Publication number Publication date
WO2003024465A2 (de) 2003-03-27
MXPA04002592A (es) 2005-08-26
KR20040041619A (ko) 2004-05-17
EA006164B1 (ru) 2005-10-27
ATE293985T1 (de) 2005-05-15
DE50202941D1 (de) 2005-06-02
US20050019437A1 (en) 2005-01-27
EP1427430B1 (de) 2005-04-27
PT1427430E (pt) 2005-08-31
JP2005503404A (ja) 2005-02-03
US20080300230A1 (en) 2008-12-04
BR0212598A (pt) 2004-10-13
DK1427430T3 (da) 2005-05-30
US20120071501A1 (en) 2012-03-22
AU2002362365A1 (en) 2003-04-01
EP1427430A2 (de) 2004-06-16
US7413754B2 (en) 2008-08-19
UA78228C2 (en) 2007-03-15
DE10146159A1 (de) 2003-04-10
ES2238631T3 (es) 2005-09-01
PL206937B1 (pl) 2010-10-29
EA200400461A1 (ru) 2004-08-26
WO2003024465A3 (de) 2003-10-09

Similar Documents

Publication Publication Date Title
WO2010054296A3 (en) Devices and methods for treating and/or preventing diseases
WO2008028076A3 (en) Therapeutic devices for the treatment of various conditions of a female individual
WO2004065423A3 (de) Erkennungsmoleküle zur behandlung und detektion von tumoren
MX2022009759A (es) El uso de 1-(4-ciano-3-trifluorometil-fenil)-3-[7-(4-ciano-3-trifl uorometil-fenil)-6-tioxo-5-p-tolilo-5,7-diazaespiro[3.4]oct-8-ili deno]-tiourea.
IL169897A0 (en) Sustituted heterocycles
PT1594833E (pt) Derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
MXPA03000188A (es) Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.
PL370370A1 (pl) Zastosowanie ekstraktów z roślin rodzaju Cimicifuga jako organoselektywnych środków leczniczych do leczenia chorób układu moczowo-płciowego zależnychod hormonów płciowych
WO2008039409A8 (en) Methods and kits for use in the treatment and prevention of diseases or conditions of the immune system or infectious diseases
WO2002087503A3 (en) Compositions and methods for treating colorectal polyps and cancer
MXPA03004537A (es) Derivados sustituidos con ciclohexano y uso de los mismos en medicamentos para tratar enfermedades cardiovasculares.
GB0021776D0 (en) The treatment of inflammatory disorders
MY140305A (en) Combination of growth regulator factors with hormones for neoplasia treatment
IL181713A0 (en) Use of il-17f for the treatment and/or prevention of neurological diseases
WO2007031853A3 (en) Therapeutic combination of hamlet and a hdac inhibitor to treat cancer
WO2005023288A8 (en) Treatment of fibrotic disease
Bloomfield Update on emerging infections: news from the Centers for Disease Control and Prevention. Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections
TNSN08062A1 (en) Microparticle compositions of the topoisomerase i inhibitor 7-tert-butoxyiminomethylcamptothecin
TW200733969A (en) Extract of gentianae macrophyllae radix for the treatment of dermatological diseases
PL1732574T3 (pl) Zastosowanie o-ATP do leczenia chorób związanych z angiogenezą
TW200640478A (en) Herbal composition for treatment of arthritic disorders, skin inflammatory disorders and pain
UA42244A (uk) Засіб суслова-підгаєвської для лікування злоякісних пухлин
TW200503750A (en) FSH and LH pharmaceutical formulations
UA33545A (uk) Спосіб лікування дакріоциститу

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20130916